Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy

Pakistan Journal of Pharmaceutical Sciences

Volumn 25, Issue 1, 2012, Pages 123-129

  Shahid, Syed Muhammad ^a   Nawab, Syeda Nuzhat ^a   Shaikh, Rozeena ^a   Mahboob, Tabassum ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Diabetes; Dyslipidemia; Endothelial dysfunction; Hyperglycemia; Hypertension; Nephropathy

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; SIALIC ACID; TRIACYLGLYCEROL; UREA;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DIET RESTRICTION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAKISTAN; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ALBUMINURIA; BLOOD GLUCOSE; CHOLESTEROL; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; NITRIC OXIDE; TRIGLYCERIDES; UREA;

EID: 84855401727     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W and Sowers J (2000). Preserving renal function in adults with hypertension and diabetes: A consensus approach: National Kidney Foundation Hypertension and diabetes Executive Committee Working Group. Am. J. Kidney Dis., 36: 646-661.
2. Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W and Topol EH (2002). Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am. J. Cardiol., 90: 625-628. (Pubitemid 35264538)
3. Braam B, de Koning EJ and Mees EJ (2004). Diabetic nephropathy: the role of blood pressure and extracellular volume in its pathogenesis and treatment. Ned. Tijdschr. Geneeskd., 148(5): 212-217. (Pubitemid 38168255)
4. Caramori ML, Fioretto P and Mauer M (2003). Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients. Diabetes, 52: 1036-1040.
5. Carey RM and Siragy HM (2003). The intrarenal renin angiotensin system and diabetic nephropathy. Trends in Endcrionol. Metab., 14: 274-280.
6. Carlos AP, Parrot MA and Raskin P (2002). The treatment of hypertension in adult patients with diabetes. Diabetes Care, 25: 134-147.
7. Colhoun HM, Lee ET, Bennet PH, Lu M, Keen H, Wang SL, Stevens LK and Fuller JH (2001). Risk factors for renal failure: the WHO multinational study of vascular disease in diabetes. Diabetologia., 44: S46-S53. (Pubitemid 32844112)
8. Crook M (1993). The determination of plasma Sialic acid. Clin. Biochem., 26: 31-37.
9. Crook MA, Pickup JC, Lumb PJ, Georgino F, Webb DJ and Fuller JH (2001). Relationship between Plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes. Diabetes Care, 24: 316-322. (Pubitemid 32119131)
10. Deferrari G, Repetto M, Calvi C, Ciabattoni M, Rossi C and Robaudo C (1998). Diabetic nephropathy: from micro- to macroalbuminuria. Nephrol. Dial. Transplant., 13(Suppl 8): 11-15. (Pubitemid 28532588)
11. El Atat F, McFarlane SI and Sower JR (2004). Diabetes, hypertension and cardiovascular derangements: pathophysiology and management. Curr. Hypertens. Rep., 6(3): 215-223. (Pubitemid 39359564)
12. Evans TC and Capell P (2000). Diabetic nephropathy. Clin. Diab., 18: 1-15.
13. Goligorsky MS, Chen J and Brodsky S (2001). Endothelial cell dysfunction leading to diabetic nephropathy: Focus on nitric oxide. Hypertension, 37: 744-748. (Pubitemid 32199060)
14. Hasan ZU, Zia S and Maracy M (2004). Baseline disease knowledge assessment in Patients with type 2 diabetes in a rural area of Northwestern of Pakistan. J. Pak. Med. Assoc., 54(2): 67-73. (Pubitemid 38525203)
15. James PE, Lang D, Tufnell-Barret T, Milsom AB and Frenneaux MP (2004). Vasorelaxation by red blood cells and impairment in diabetes. Circ. Res., 94: 976.
16. Jeremy WT (2003). Treating hypertension in diabetic nephropathy. Diabetes Care, 26(6): 1802-1805.
17. Khuwaja AK, Rafique G, White F and Azam SI (2004). Macrovascular complications and their associated factors among persons with type 2 diabetes in Karachi, Pakistan - A multi center Study. J. Pak. Med. Assoc., 54: 60-66. (Pubitemid 38525202)
18. Komers R, Lindsley JN, Oyama TT, Allison KM and Anderson S (2000). Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am. J. Physiol. Renal Physiol., 279: F573-F583.
19. Krishnamurti U and Steffes MW (2001). Glycohemoglobin: A primary predictor of the development or reversal of complications of diabetes mellitus. Clin. Chem., 47: 1157-1165. (Pubitemid 32579102)
20. Lewis EJ (2002). The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes. Am. J. Hypertens., 15: 123S-128S.
21. Mantovani A and Bussolino F (1997). Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today, 18: 231-240. (Pubitemid 27219618)
22. Morgan CL, Currie CJ and Peters JR (2000). Relationship between diabetes and mortality: A population study using record linkage. Diabetes Care, 23: 1103-1107. (Pubitemid 30616796)
23. Multiple Risk Factor Intervention Trial Research Group (MRFITR) (1993). Diabetes, other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care, 16: 434-444.
24. Nuttall FQ (1998). Comparison of percent total GHb with percent HbA1c in people with and without known diabetes. Diabetes Care, 21: 1475-1480.
25. Pflueger AC, Larson TS, Hagl S and Knox FG (1999). Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 277: R725-R733. (Pubitemid 29458144)
26. Shahid SM and Tabassum M (2006). Correlation between frequent risk factors or diabetic nephropathy and serum sialic acid. Asian J. Biochem., 1(3): 244-250.
27. Shera AS, Jawad F, Maqsood SJ, Azhar M and Ahmed U (2004). Prevalence of chronic complications and associated factors in type 2 diabetes. J. Pak. Med. Assoc., 54: 54-59. (Pubitemid 38525201)
28. Shi WX, Li XY and Li J (2004). The morbidity of chronic diabetic complication with logistic regression analysis of related potential risk factors. Zhonghua Liu Xing Bing Xue Za Zhi, 25(1): 60-64.
29. Smarason AK, Allman KG, Young D and Redman CW (1997). Elevated levels of serum nitrate, a stable end product of nitric oxide in women with preeclampsia. Br. J. Obstet. Gynaecol., 104: 538-543. (Pubitemid 27240417)
30. Sriharan M, Reichelt AJ, Opperman MR, Duncan BB, Mengue SS, Crook MA and Schmidt MI (2002). Total sialic acid and associated elements of the metabolic syndrome in women with and without previous gestational diabetes. Diabetes Care, 25: 1331-1335. (Pubitemid 41071141)
31. Star R, Hostetter T and Hortin GL (2002). New markers for kidney disease. Clin. Chem., 48: 1375-1376. (Pubitemid 34925769)
32. Tarn AC and Drury PL (1994). Blood pressure in children, adolescents and young adults with type 1 diabetes. Diabetologia, 29: 275-281.
33. Thomas MC, Rosengard-Barlund M, Mills V, Bonnback M, Thomas S, Forsblom C, Cooper ME, Takinen MR, Viberti G and Groop PH (2006). Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care, 29(2): 317-322. (Pubitemid 44106511)
34. Vallejo S, Angulo J, Peiro C, Nevado J, Sanchez-Ferrer A, Petidier R, Sanchez-Ferrer CF and Rodriguez- Manas L (2000). Highly glycated oxyhemoglobin impairs nitric oxide relaxations in human mesenteric microvessels. Diabetologia, 43: 83-90. (Pubitemid 30129306)
35. Wannamettee SG, Shaper AG and Alberti KG (2000). Physical activity, metabolic factors and the incidence of coronary heart diseases and type 2 diabetes. Arch. Intern. Med., 160: 2108-2116.
36. Williamson DE, Thompson TJ, Thun M (2000). Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care, 23: 1499-1504.
37. World Health Organization (2004). The Diabetes Program, available at http://www.who.int/diabetes/en/. September 21, 2004.
38. Yokoyama H, Jensen JS, Myrup B, Mathiesen E R, Ronn B and Decken T (1996). Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. Diabetes Care, 19: 435-440.
39. Zimmermann J, Wanner C and Quaschning T (1999). Lipid management in type 2 diabetes with nephropathy. In TRitz E and Rychlík I: Nephropoathy in type 2 Diabetes. Oxford Clinical Nephrology Series. Oxford University Press, Oxford, pp.137-157.